Schidlovsky noted that Curaleaf, which operates dispensaries and cultivation facilities in 12 states, is ready to serve patients in New Jersey’s expanding medical marijuana program.
“Receiving approval to launch these products is an important milestone in the progression of Curaleaf’s operations as well as in New Jersey’s medical cannabis program,” said Schidlovsky. “As the largest dispensary on the East Coast, serving hundreds of patients daily, Curaleaf has the resources and production capacity to reliably market and distribute new products that our patients depend on to live life well.”
The first offering of vape cartridges from Curaleaf NJ is now available and consists of four strain specific options including Lavender, Strawberry Cough, Cookies, and Canna-Tsu.